$ABBV AbbVie Q3 Earnings
Adj. EPS $3.82, est. $3.74 Net rev. $17.40B, est. $17.34B Skyrizi rev. $5.78B, est. $5.74B Rinvoq rev. $2.71B, est. $2.70B Humira rev. $683M, est. $679.3M Imbruvica rev. $522M, est. $527.3M Sees FY Adj. EPS $13.95 to $13.99, saw $13.76 to $13.96
Adj. EPS $3.82, est. $3.74 Net rev. $17.40B, est.
$17.34B Skyrizi rev. $5.78B, est. $5.74B Rinvoq rev. $2.71B, est.
$2.70B Humira rev. $683M, est. $679.3M Imbruvica rev. $522M, est.
$527.3M Sees FY Adj. EPS $13.95 to $13.99, saw $13.76 to $13.96